Prollenium Medical Technologies Inc. announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler

AURORA, ON, Aug. 18, 2017 -- (Healthcare Sales & Marketing Network) - Prollenium Medical Technologies Inc., a leading medical device manufacturer, announced today its United States (U.S.) Food and Drug Administration (FDA) approval for its cross-linked hy... Devices, Dermatology, FDA Prollenium Medical Technologies, hyaluronic acid, dermal filler
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news